| 1 | UNC9426, a Potent and Orally Bioavailable TYRO3-Specific Inhibitor. (Kong D, Yang X, Judd S, Yan D, Springborn S, Stashko MA, Kidwell A, Huelse JM, Kireev D, Graham DK, DeRyckere D, Branchford B, Wang X) J Med Chem 2025 Mar 27;68(6):6665-6682 1 Citation |
| 1 | Alterations in visible light exposure modulate platelet function and regulate thrombus formation. (Andraska EA, Denorme F, Kaltenmeier C, Arivudainabi A, Mihalko EP, Dyer M, Annarapu GK, Zarisfi M, Loughran P, Ozel M, Williamson K, Mota Alvidrez RI, Thomas K, Shiva S, Shea SM, Steinman RA, Campbell RA, Rosengart MR, Neal MD) J Thromb Haemost 2025 Jan;23(1):123-138 2 Citations |
| 1 | Oxidative Stress-Induced Platelet Apoptosis/Activation: Alleviation by Purified Curcumin via ASK1-JNK/p-38 Pathway. (Manikanta K, Paul M, Sandesha VD, Mahalingam SS, Ramesh TN, Harishkumar K, Koundinya SS, Naveen S, Kemparaju K, Girish KS) Biochemistry (Mosc) 2024 Mar;89(3):417-430 6 Citations |
| 1 | Hypofibrinogenemia with preserved hemostasis and protection from thrombosis in mice with an Fga truncation mutation. (Hur WS, Paul DS, Bouck EG, Negrón OA, Mwiza JM, Poole LG, Cline-Fedewa HM, Clark EG, Juang LJ, Leung J, Kastrup CJ, Ugarova TP, Wolberg AS, Luyendyk JP, Bergmeier W, Flick MJ) Blood 2022 Mar 03;139(9):1374-1388 24 Citations |
| 2 | Platelet and myeloid cell phenotypes in a rat model of Fabry disease. (Kanack AJ, Aoki K, Tiemeyer M, Dahms NM) FASEB J 2021 Aug;35(8):e21818 4 Citations |
| 1 | Platelet-rich aggregates in MNC collection circuit. (Amin N, Cho JH, McMullen P, Uraizee I, Wool G, Su L) Transfusion 2021 Apr;61(4):1010-1011 1 Citation |
| 1 | Functional Assessment of Platelet Dense Granule ATP Release. (Cho JH, Wool GD, Tjota MY, Gutierrez J, Mikrut K, Miller JL) Am J Clin Pathol 2021 May 18;155(6):863-872 6 Citations |
| 4 | Nitric oxide added to the sweep gas of the oxygenator during cardiopulmonary bypass in infants: A pilot randomized controlled trial. (Niebler RA, Chiang-Ching H, Daley K, Janecke R, Jobe SM, Mitchell ME, Varner C, Woods K, Scott JP) Artif Organs 2021 Jan;45(1):22-28 15 Citations |
| 1 | Antiplatelet properties of Pim kinase inhibition are mediated through disruption of thromboxane A2 receptor signaling. (Unsworth AJ, Bye AP, Sage T, Gaspar RS, Eaton N, Drew C, Stainer A, Kriek N, Volberding PJ, Hutchinson JL, Riley R, Jones S, Mundell SJ, Cui W, Falet H, Gibbins JM) Haematologica 2021 Jul 01;106(7):1968-1978 15 Citations |
| 1 | Glanzmann thrombasthenia: genetic basis and clinical correlates. (Botero JP, Lee K, Branchford BR, Bray PF, Freson K, Lambert MP, Luo M, Mohan S, Ross JE, Bergmeier W, Di Paola J, ClinGen Platelet Disorder Variant Curation Expert Panel) Haematologica 2020 Apr;105(4):888-894 119 Citations |
| 1 | Acquired Glanzmann's thrombasthenia: Diagnosis aided by platelet aggregation mixing study. (Compton F, Sarode R, Rutherford C, Curtis B, De Simone N) Haemophilia 2020 Mar;26(2):e41-e43 4 Citations |
| 2 | The parmodulin NRD-21 is an allosteric inhibitor of PAR1 Gq signaling with improved anti-inflammatory activity and stability. (Gandhi DM, Rosas R Jr, Greve E, Kentala K, D-R Diby N, Snyder VA, Stephans A, Yeung THW, Subramaniam S, DiMilo E, Kurtenbach KE, Arnold LA, Weiler H, Dockendorff C) Bioorg Med Chem 2019 Sep 01;27(17):3788-3796 13 Citations |
| 1 | Platelet-derived extracellular vesicles released after trauma promote hemostasis and contribute to DVT in mice. (Dyer MR, Alexander W, Hassoune A, Chen Q, Brzoska T, Alvikas J, Liu Y, Haldeman S, Plautz W, Loughran P, Li H, Boone B, Sadovsky Y, Sundd P, Zuckerbraun BS, Neal MD) J Thromb Haemost 2019 Oct;17(10):1733-1745 72 Citations |
| 2 | Platelet decoys inhibit thrombosis and prevent metastatic tumor formation in preclinical models. (Papa AL, Jiang A, Korin N, Chen MB, Langan ET, Waterhouse A, Nash E, Caroff J, Graveline A, Vernet A, Mammoto A, Mammoto T, Jain A, Kamm RD, Gounis MJ, Ingber DE) Sci Transl Med 2019 Feb 13;11(479) 71 Citations |
| 1 | Delivery of mRNA to platelets using lipid nanoparticles. (Novakowski S, Jiang K, Prakash G, Kastrup C) Sci Rep 2019 Jan 24;9(1):552 32 Citations |
| 1 | Defective collagen binding and increased bleeding in a murine model of von Willebrand disease affecting collagen IV binding. (Slobodianuk TL, Kochelek C, Foeckler J, Kalloway S, Weiler H, Flood VH) J Thromb Haemost 2019 Jan;17(1):63-71 13 Citations |
| 1 | The small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis. (Branchford BR, Stalker TJ, Law L, Acevedo G, Sather S, Brzezinski C, Wilson KM, Minson K, Lee-Sherick AB, Davizon-Castillo P, Ng C, Zhang W, Neeves KB, Lentz SR, Wang X, Frye SV, Shelton Earp H 3rd, DeRyckere D, Brass LF, Graham DK, Di Paola JA) J Thromb Haemost 2018 Feb;16(2):352-363 27 Citations |
| 1 | Apolipoprotein A-I Modulates Atherosclerosis Through Lymphatic Vessel-Dependent Mechanisms in Mice. (Milasan A, Jean G, Dallaire F, Tardif JC, Merhi Y, Sorci-Thomas M, Martel C) J Am Heart Assoc 2017 Sep 22;6(9) 36 Citations |
| 1 | Decreased thromboembolic stroke but not atherosclerosis or vascular remodelling in mice with ROCK2-deficient platelets. (Sladojevic N, Oh GT, Kim HH, Beaulieu LM, Falet H, Kaminski K, Freedman JE, Liao JK) Cardiovasc Res 2017 Sep 01;113(11):1307-1317 26 Citations |
| 1 | An Investigation of Extracellular Histones in Pig-To-Baboon Organ Xenotransplantation. (Li T, Lee W, Hara H, Long C, Ezzelarab M, Ayares D, Huang H, Wang Y, Esmon CT, Cooper DKC, Iwase H) Transplantation 2017 Oct;101(10):2330-2339 38 Citations |
| 2 | Platelet Activation and Thrombus Formation over IgG Immune Complexes Requires Integrin αIIbβ3 and Lyn Kinase. (Zhi H, Dai J, Liu J, Zhu J, Newman DK, Gao C, Newman PJ) PLoS One 2015;10(8):e0135738 31 Citations |
| 1 | The interface of inflammation and subclinical atherosclerosis in granulomatosis with polyangiitis (Wegener's): a preliminary study. (Hajj-Ali RA, Major J, Langford C, Hoffman GS, Clark T, Zhang L, Sun Z, Silverstein RL) Transl Res 2015 Oct;166(4):366-74 17 Citations |
| 1 | Thymidine phosphorylase participates in platelet signaling and promotes thrombosis. (Li W, Gigante A, Perez-Perez MJ, Yue H, Hirano M, McIntyre TM, Silverstein RL) Circ Res 2014 Dec 05;115(12):997-1006 43 Citations |
| 1 | Exosome poly-ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro-atherothombotic cellular functions. (Srikanthan S, Li W, Silverstein RL, McIntyre TM) J Thromb Haemost 2014 Nov;12(11):1906-17 114 Citations |
| 1 | Blood platelet kinetics and platelet transfusion. (Aster RH) J Clin Invest 2013 Nov;123(11):4564-5 12 Citations |
| 1 | Proteasome proteolysis supports stimulated platelet function and thrombosis. (Gupta N, Li W, Willard B, Silverstein RL, McIntyre TM) Arterioscler Thromb Vasc Biol 2014 Jan;34(1):160-8 51 Citations |
| 1 | Kindlin-2 regulates hemostasis by controlling endothelial cell-surface expression of ADP/AMP catabolic enzymes via a clathrin-dependent mechanism. (Pluskota E, Ma Y, Bledzka KM, Bialkowska K, Soloviev DA, Szpak D, Podrez EA, Fox PL, Hazen SL, Dowling JJ, Ma YQ, Plow EF) Blood 2013 Oct 03;122(14):2491-9 39 Citations |
| 2 | C560Rβ3 caused platelet integrin αII b β3 to bind fibrinogen continuously, but resulted in a severe bleeding syndrome and increased murine mortality. (Fang J, Nurden P, North P, Nurden AT, Du LM, Valentin N, Wilcox DA) J Thromb Haemost 2013 Jun;11(6):1163-71 19 Citations |
| 1 | Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo. (Zhi H, Rauova L, Hayes V, Gao C, Boylan B, Newman DK, McKenzie SE, Cooley BC, Poncz M, Newman PJ) Blood 2013 Mar 07;121(10):1858-67 87 Citations |
| 1 | P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery disease. (Timur AA, Murugesan G, Zhang L, Aung PP, Barnard J, Wang QK, Gaussem P, Silverstein RL, Bhatt DL, Kottke-Marchant K) Int J Lab Hematol 2012 Oct;34(5):473-83 35 Citations |
| 1 | Cadherin 6 has a functional role in platelet aggregation and thrombus formation. (Dunne E, Spring CM, Reheman A, Jin W, Berndt MC, Newman DK, Newman PJ, Ni H, Kenny D) Arterioscler Thromb Vasc Biol 2012 Jul;32(7):1724-31 52 Citations |
| 1 | Advanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36. (Zhu W, Li W, Silverstein RL) Blood 2012 Jun 21;119(25):6136-44 92 Citations |
| 1 | Structure-guided design of a high-affinity platelet integrin αIIbβ3 receptor antagonist that disrupts Mg²⁺ binding to the MIDAS. (Zhu J, Choi WS, McCoy JG, Negri A, Zhu J, Naini S, Li J, Shen M, Huang W, Bougie D, Rasmussen M, Aster R, Thomas CJ, Filizola M, Springer TA, Coller BS) Sci Transl Med 2012 Mar 14;4(125):125ra32 80 Citations |
| 3 | Residues within a lipid-associated segment of the PECAM-1 cytoplasmic domain are susceptible to inducible, sequential phosphorylation. (Paddock C, Lytle BL, Peterson FC, Holyst T, Newman PJ, Volkman BF, Newman DK) Blood 2011 Jun 02;117(22):6012-23 38 Citations |
| 1 | Vav guanine nucleotide exchange factors link hyperlipidemia and a prothrombotic state. (Chen K, Li W, Major J, Rahaman SO, Febbraio M, Silverstein RL) Blood 2011 May 26;117(21):5744-50 62 Citations |
| 1 | Lyn and PECAM-1 function as interdependent inhibitors of platelet aggregation. (Ming Z, Hu Y, Xiang J, Polewski P, Newman PJ, Newman DK) Blood 2011 Apr 07;117(14):3903-6 50 Citations |
| 2 | Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain. (Gao C, Boylan B, Bougie D, Gill JC, Birenbaum J, Newman DK, Aster RH, Newman PJ) J Clin Invest 2009 Mar;119(3):504-11 58 Citations |
| 1 | Fibrinogen Hershey IV: a novel dysfibrinogen with a gammaV411I mutation in the integrin alpha(IIb)beta(3) binding site. (Flood VH, Al-Mondhiry HA, Rein CM, Alexander KS, Lovely RS, Shackleton KM, David LL, Farrell DH) Thromb Haemost 2008 Jun;99(6):1008-12 7 Citations |
| 1 | Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice. (Ghosh A, Li W, Febbraio M, Espinola RG, McCrae KR, Cockrell E, Silverstein RL) J Clin Invest 2008 May;118(5):1934-43 150 Citations |
| 1 | Platelet secretion: indiscriminately spewed forth or highly orchestrated? (White GC 2nd, Rompietti R) J Thromb Haemost 2007 Oct;5(10):2006-8 35 Citations |
| 1 | Paxillin family members function as Csk-binding proteins that regulate Lyn activity in human and murine platelets. (Rathore VB, Okada M, Newman PJ, Newman DK) Biochem J 2007 Apr 15;403(2):275-81 24 Citations |
| 1 | The interaction of thrombin with blood platelets. (Lundblad RL, White GC 2nd) Platelets 2005 Nov;16(7):373-85 52 Citations |
| 3 | Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia. (Fang J, Hodivala-Dilke K, Johnson BD, Du LM, Hynes RO, White GC 2nd, Wilcox DA) Blood 2005 Oct 15;106(8):2671-9 85 Citations |
| 1 | Integrin alpha(IIb)beta3 signals lead cofilin to accelerate platelet actin dynamics. (Falet H, Chang G, Brohard-Bohn B, Rendu F, Hartwig JH) Am J Physiol Cell Physiol 2005 Oct;289(4):C819-25 32 Citations |
| 1 | Sustained engraftment post bone marrow transplant despite anti-platelet antibodies in Glanzmann thrombasthenia. (Flood VH, Johnson FL, Boshkov LK, Thomas GA, Nugent DJ, Bakke AC, Nicholson HS, Tilford D, Brown MP, Godder KT) Pediatr Blood Cancer 2005 Dec;45(7):971-5 35 Citations |
| 1 | Rap1b is required for normal platelet function and hemostasis in mice. (Chrzanowska-Wodnicka M, Smyth SS, Schoenwaelder SM, Fischer TH, White GC 2nd) J Clin Invest 2005 Mar;115(3):680-7 282 Citations |
| 1 | Membrane-potential-dependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids. (Krötz F, Riexinger T, Buerkle MA, Nithipatikom K, Gloe T, Sohn HY, Campbell WB, Pohl U) Arterioscler Thromb Vasc Biol 2004 Mar;24(3):595-600 115 Citations |
| 1 | Glycosylation restores survival of chilled blood platelets. (Hoffmeister KM, Josefsson EC, Isaac NA, Clausen H, Hartwig JH, Stossel TP) Science 2003 Sep 12;301(5639):1531-4 253 Citations |
| 2 | Mechanisms and implications of platelet discoid shape. (Italiano JE Jr, Bergmeier W, Tiwari S, Falet H, Hartwig JH, Hoffmeister KM, André P, Wagner DD, Shivdasani RA) Blood 2003 Jun 15;101(12):4789-96 147 Citations |
| 1 | Platelet endothelial cell adhesion molecule-1 serves as an inhibitory receptor that modulates platelet responses to collagen. (Patil S, Newman DK, Newman PJ) Blood 2001 Mar 15;97(6):1727-32 148 Citations |
| 1 | A frameshift mutation at Gly975 in the transmembrane domain of GPIIb prevents GPIIb-IIIa expression--analysis of two novel mutations in a kindred with type I glanzmann thrombasthenia. (Scott JP 3rd, Scott JP 2nd, Chao YL, Newman PJ, Ward CM) Thromb Haemost 1998 Oct;80(4):546-50 10 Citations |
| 1 | The effect of inhaled nitric oxide therapy on bleeding time and platelet aggregation in neonates. (George TN, Johnson KJ, Bates JN, Segar JL) J Pediatr 1998 Apr;132(4):731-4 90 Citations |
| 1 | Giant platelet disorder in a patient with type 2B von Willebrand's disease. (Moll S, Lazarowski AR, White GC 2nd) Am J Hematol 1998 Jan;57(1):62-7 13 Citations |
| 1 | Heparin-induced thrombocytopenia and thrombosis. (Aster RH) N Engl J Med 1995 May 18;332(20):1374-6 187 Citations |
| 1 | Modulation of platelet function by reactive oxygen metabolites. (Ambrosio G, Golino P, Pascucci I, Rosolowsky M, Campbell WB, DeClerck F, Tritto I, Chiariello M) Am J Physiol 1994 Jul;267(1 Pt 2):H308-18 62 Citations |
| 1 | Incorporation of Rap 1b into the platelet cytoskeleton is dependent on thrombin activation and extracellular calcium. (Fischer TH, Gatling MN, McCormick F, Duffy CM, White GC 2nd) J Biol Chem 1994 Jun 24;269(25):17257-61 33 Citations |
| 2 | Decrease in vascular TxA2 receptors in a subgroup of rabbits unresponsive to a TxA2 mimetic. (Buzzard CJ, Pfister SL, Halushka PV, Campbell WB) Am J Physiol 1994 Jun;266(6 Pt 2):H2320-6 15 Citations |
| 1 | Calcium mobilisation controls tyrosine protein phosphorylation independently of the activation of protein kinase C in human platelets. (Falet H, Rendu F) FEBS Lett 1994 May 23;345(1):87-91 20 Citations |
| 1 | Lipid fluidity modulates platelet aggregation and agglutination in vitro. (Vlasic N, Medow MS, Schwarz SM, Pritchard KA Jr, Stemerman MB) Life Sci 1993;53(13):1053-60 23 Citations |
| 1 | Response of human platelets to activating monoclonal antibodies: importance of Fc gamma RII (CD32) phenotype and level of expression. (Tomiyama Y, Kunicki TJ, Zipf TF, Ford SB, Aster RH) Blood 1992 Nov 01;80(9):2261-8 79 Citations |
| 1 | Global myocardial ischemia and reperfusion impair endothelium-dependent relaxations to aggregating platelets in the canine coronary artery. A possible cause of vasospasm after cardiopulmonary bypass. (Pearson PJ, Lin PJ, Schaff HV) J Thorac Cardiovasc Surg 1992 Jun;103(6):1147-54 60 Citations |
| 1 | ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries. (Yao SK, Ober JC, McNatt J, Benedict CR, Rosolowsky M, Anderson HV, Cui K, Maffrand JP, Campbell WB, Buja LM) Circ Res 1992 Jan;70(1):39-48 108 Citations |
| 1 | Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis. (Yao SK, Benedict CR, Rosolowsky M, McNatt J, Falinska B, Campbell WB, Buja LM, Willerson JT) J Mol Cell Cardiol 1991 Apr;23(4):473-82 18 Citations |
| 1 | Synthesis and biological activity of epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells. (Rosolowsky M, Falck JR, Campbell WB) Adv Prostaglandin Thromboxane Leukot Res 1991;21A:213-6 13 Citations |
| 1 | Acute impairment of endothelium-dependent relaxations to aggregating platelets following reperfusion injury in canine coronary arteries. (Pearson PJ, Schaff HV, Vanhoutte PM) Circ Res 1990 Aug;67(2):385-93 153 Citations |
| 1 | Long-term impairment of endothelium-dependent relaxations to aggregating platelets after reperfusion injury in canine coronary arteries. (Pearson PJ, Schaff HV, Vanhoutte PM) Circulation 1990 Jun;81(6):1921-7 131 Citations |
| 1 | Effect of dietary omega-3 fatty acid on serum lipids, platelet function, and atherosclerosis in Watanabe heritable hyperlipidemic rabbits. (Clubb FJ Jr, Schmitz JM, Butler MM, Buja LM, Willerson JT, Campbell WB) Arteriosclerosis 1989;9(4):529-37 48 Citations |
| 1 | Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators. (Golino P, Ashton JH, Buja LM, Rosolowsky M, Taylor AL, McNatt J, Campbell WB, Willerson JT) Circulation 1989 Jan;79(1):154-66 199 Citations |
| 1 | Human anti-PlE1 antibody recognizes epitopes associated with the alpha subunit of platelet glycoprotein Ib. (Furihata K, Hunter J, Aster RH, Koewing GR, Shulman NP, Kunicki TJ) Br J Haematol 1988 Jan;68(1):103-10 25 Citations |
| 1 | Cultured bovine coronary arterial endothelial cells synthesize HETEs and prostacyclin. (Revtyak GE, Johnson AR, Campbell WB) Am J Physiol 1988 Jan;254(1 Pt 1):C8-19 49 Citations |
| 1 | Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses. (Ashton JH, Ogletree ML, Michel IM, Golino P, McNatt JM, Taylor AL, Raheja S, Schmitz J, Buja LM, Campbell WB) Circulation 1987 Oct;76(4):952-9 87 Citations |
| 1 | Use of PGE1 for preparation of platelet concentrates. (Menitove JE, Frenzke M, Aster RH) Transfusion 1986;26(4):346-50 26 Citations |
| 1 | Thrombospondin: a versatile multifunctional glycoprotein. (Silverstein RL, Leung LL, Nachman RL) Arteriosclerosis 1986;6(3):245-53 54 Citations |
| 1 | Identification of glycoprotein Ib as a target for autoantibody in idiopathic (autoimmune) thrombocytopenic purpura. (Szatkowski NS, Kunicki TJ, Aster RH) Blood 1986 Feb;67(2):310-5 77 Citations |
| 1 | Synthesis of dihomoprostaglandins from adrenic acid (7,10,13,16-docosatetraenoic acid) by human endothelial cells. (Campbell WB, Falck JR, Okita JR, Johnson AR, Callahan KS) Biochim Biophys Acta 1985 Oct 23;837(1):67-76 53 Citations |
| 1 | Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors. (Apprill P, Schmitz JM, Campbell WB, Tilton G, Ashton J, Raheja S, Buja LM, Willerson JT) Circulation 1985 Aug;72(2):397-405 |
| 1 | Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia. (Schmitz JM, Apprill PG, Buja LM, Willerson JT, Campbell WB) Circ Res 1985 Aug;57(2):223-31 |
| 1 | Enhancement of the antiaggregatory activity of prostacyclin by propranolol in human platelets. (Callahan KS, Johnson AR, Campbell WB) Circulation 1985 Jun;71(6):1237-46 16 Citations |
| 1 | Effect of active site-modified thrombin on the hydrolysis of platelet-associated glycoprotein V by native thrombin. (Knupp CL, White GC 2nd) Blood 1985 Mar;65(3):578-83 13 Citations |
| 1 | Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms. (Willerson JT, Campbell WB, Winniford MD, Schmitz J, Apprill P, Firth BG, Ashton J, Smitherman T, Bush L, Buja LM) Am J Cardiol 1984 Dec 01;54(10):1349-54 121 Citations |
| 1 | The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries. (Bush LR, Campbell WB, Kern K, Tilton GD, Apprill P, Ashton J, Schmitz J, Buja LM, Willerson JT) Circ Res 1984 Nov;55(5):642-52 |
| 1 | Use of prostacyclin to inhibit activation of platelets during preparation of platelet concentrates. (Menitove JE, Frenzke M, Aster RH) Transfusion 1984;24(6):528-31 22 Citations |
| 1 | Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries. (Bush LR, Campbell WB, Buja LM, Tilton GD, Willerson JT) Circulation 1984 Jun;69(6):1161-70 |
| 1 | The effect of platelet inhibitors on glycoprotein V hydrolysis by thrombin. (Knupp CL, White GC 2nd) Thromb Res 1984 May 01;34(3):225-31 12 Citations |
| 1 | Interactions of the arterial wall, plaque, and platelets in myocardial ischemia and infarction. (Hillis LD, Hirsh PD, Campbell WB, Firth BG) Cardiovasc Clin 1983;14(1):31-44 7 Citations |
| 1 | Anti-platelet activity of beta-adrenergic antagonists: inhibition of thromboxane synthesis and platelet aggregation in patients receiving long-term propranolol treatment. (Campbell WB, Johnson AR, Callahan KS, Graham RM) Lancet 1981 Dec 19-26;2(8260-61):1382-4 105 Citations |
| 1 | Platelet satellitism and phagocytosis by neutrophils: association with antiplatelet antibodies and lymphoma. (White LA Jr, Brubaker LH, Aster RH, Henry PH, Adelstein EH) Am J Hematol 1978;4(4):313-23 18 Citations |
| 1 | Predictive value of cross-matching for transfusion of platelet concentrates to alloimmunized recipients. (Filip DJ, Duquesnoy RJ, Aster RH) Am J Hematol 1976;1(4):471-9 34 Citations |
| 1 | A study of variables affecting the quality of platelets stored at "room temperature". (Kunicki TJ, Tuccelli M, Becker GA, Aster RH) Transfusion 1975;15(5):414-21 340 Citations |
| 1 | Platelet migration inhibition: a new method for detection of platelet antibodies. (Duquesnoy RJ, Lorentsen DF, Aster RH) Blood 1975 Jun;45(6):741-7 19 Citations |
| 1 | Post-transfusion purpura: immunologic aspects and therapy. (Abramson N, Eisenberg PD, Aster RH) N Engl J Med 1974 Nov 28;291(22):1163-6 52 Citations |
© 2026 Clinical & Translational Science Institute